Cell based therapies for ischemic stroke: From basic science to bedside

Progress in Neurobiology

Volumn 115, Issue C, 2014, Pages 92-115

  Liu, Xinfeng ^a   Ye, Ruidong ^a   Yan, Tao ^b,c   Yu, Shan Ping ^d   Wei, Ling ^d   Xu, Gelin ^a   Fan, Xinying ^a   Jiang, Yongjun ^a   Stetler, R Anne ^e   Liu, George ^f   Chen, Jieli ^b  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b HENRY FORD HOSPITAL   (United States)

^c TIANJIN UNIVERSITY   (China)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Cell based therapies; Ischemic stroke; Neurorestoration; Stem cells

Indexed keywords

ANIMAL; BIOLOGICAL THERAPY; BRAIN ISCHEMIA; CELL-BASED THERAPIES; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL (TOPIC); HUMAN; METHODOLOGY; NEURORESTORATION; REVIEW; STEM CELL; TRANSLATIONAL RESEARCH;

CELL-BASED THERAPIES; ISCHEMIC STROKE; NEURORESTORATION; STEM CELLS;

ANIMALS; BRAIN ISCHEMIA; CELL- AND TISSUE-BASED THERAPY; CLINICAL TRIALS AS TOPIC; HUMANS; STROKE; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84891796787     PISSN: 03010082     EISSN: 18735118     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2013.11.007     Document Type: Review

References (373)

1. Abe K., Yamashita T., Takizawa S., Kuroda S., Kinouchi H., Kawahara N. Stem cell therapy for cerebral ischemia: from basic science to clinical applications. Journal of Cerebral Blood Flow and Metabolism 2012, 32:1317-1331.
2. Adamczak J., Hoehn M. In vivo imaging of cell transplants in experimental ischemia. Progress in Brain Research 2012, 201:55-78.
3. Afzal M.R., Haider H., Idris N.M., Jiang S., Ahmed R.P., Ashraf M. Preconditioning promotes survival and angiomyogenic potential of mesenchymal stem cells in the infarcted heart via NF-kappaB signaling. Antioxidants & Redox Signaling 2010, 12:693-702.
4. Aimone J.B., Deng W., Gage F.H. Resolving new memories: a critical look at the dentate gyrus, adult neurogenesis, and pattern separation. Neuron 2011, 70:589-596.
5. Akpan N., Serrano-Saiz E., Zacharia B.E., Otten M.L., Ducruet A.F., Snipas S.J., Liu W., Velloza J., Cohen G., Sosunov S.A., Frey W.H., Salvesen G.S., Connolly E.S., Troy C.M. Intranasal delivery of caspase-9 inhibitor reduces caspase-6-dependent axon/neuron loss and improves neurological function after stroke. Journal of Neuroscience 2011, 31:8894-8904.
6. Al-Khaldi A., Eliopoulos N., Martineau D., Lejeune L., Lachapelle K., Galipeau J. Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo. Gene Therapy 2003, 10:621-629.
7. Alcala-Barraza S.R., Lee M.S., Hanson L.R., McDonald A.A., Frey W.H., McLoon L.K. Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS. Journal of Drug Targeting 2010, 18:179-190.
8. Almici C., Carlo-Stella C., Wagner J.E., Rizzoli V. Umbilical cord blood as a source of hematopoietic stem cells: from research to clinical application. Haematologica 1995, 80:473-479.
9. Alvarez-Buylla A., Garcia-Verdugo J.M. Neurogenesis in adult subventricular zone. Journal of Neuroscience 2002, 22:629-634.
10. Aly A., Peterson K., Lerman A., Lerman L., Rodriguez-Porcel M. Role of oxidative stress in hypoxia preconditioning of cells transplanted to the myocardium: a molecular imaging study. Journal of Cardiovascular Surgery (Torino) 2011, 52:579-585.
11. Andres R.H., Choi R., Pendharkar A.V., Gaeta X., Wang N., Nathan J.K., Chua J.Y., Lee S.W., Palmer T.D., Steinberg G.K., Guzman R. The CCR2/CCL2 interaction mediates the transendothelial recruitment of intravascularly delivered neural stem cells to the ischemic brain. Stroke 2011, 42:2923-2931.
12. Andres R.H., Horie N., Slikker W., Keren-Gill H., Zhan K., Sun G., Manley N.C., Pereira M.P., Sheikh L.A., McMillan E.L., Schaar B.T., Svendsen C.N., Bliss T.M., Steinberg G.K. Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain. Brain 2011, 134:1777-1789.
13. Andrews E.M., Tsai S.Y., Johnson S.C., Farrer J.R., Wagner J.P., Kopen G.C., Kartje G.L. Human adult bone marrow-derived somatic cell therapy results in functional recovery and axonal plasticity following stroke in the rat. Experimental Neurology 2008, 211:588-592.
14. Andsberg G., Kokaia Z., Bjorklund A., Lindvall O., Martinez-Serrano A. Amelioration of ischaemia-induced neuronal death in the rat striatum by NGF-secreting neural stem cells. European Journal of Neuroscience 1998, 10:2026-2036.
15. Annabi B., Lee Y.T., Turcotte S., Naud E., Desrosiers R.R., Champagne M., Eliopoulos N., Galipeau J., Beliveau R. Hypoxia promotes murine bone-marrow-derived stromal cell migration and tube formation. Stem Cells 2003, 21:337-347.
16. Arslan F., Lai R.C., Smeets M.B., Akeroyd L., Choo A., Aguor E.N., Timmers L., van Rijen H.V., Doevendans P.A., Pasterkamp G., Lim S.K., de Kleijn D.P. Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. Stem Cell Research 2013, 10:301-312.
17. Arvidsson A., Collin T., Kirik D., Kokaia Z., Lindvall O. Neuronal replacement from endogenous precursors in the adult brain after stroke. Nature Medicine 2002, 8:963-970.
18. Bacigaluppi M., Pluchino S., Peruzzotti-Jametti L., Kilic E., Kilic U., Salani G., Brambilla E., West M.J., Comi G., Martino G., Hermann D.M. Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms. Brain 2009, 132:2239-2251.
19. Bang O.Y., Lee J.S., Lee P.H., Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Annals of Neurology 2005, 57:874-882.
20. Bao X., Feng M., Wei J., Han Q., Zhao H., Li G., Zhu Z., Xing H., An Y., Qin C., Zhao R.C., Wang R. Transplantation of Flk-1+ human bone marrow-derived mesenchymal stem cells promotes angiogenesis and neurogenesis after cerebral ischemia in rats. European Journal of Neuroscience 2011, 34:87-98.
21. Barbosa da Fonseca L.M., Battistella V., de Freitas G.R., Gutfilen B., Dos Santos Goldenberg R.C., Maiolino A., Wajnberg E., Rosado de Castro P.H., Mendez-Otero R., Andre C. Early tissue distribution of bone marrow mononuclear cells after intra-arterial delivery in a patient with chronic stroke. Circulation 2009, 120:539-541.
22. Barbosa da Fonseca L.M., Gutfilen B., Rosado de Castro P.H., Battistella V., Goldenberg R.C., Kasai-Brunswick T., Chagas C.L., Wajnberg E., Maiolino A., Salles Xavier S., Andre C., Mendez-Otero R., de Freitas G.R. Migration and homing of bone-marrow mononuclear cells in chronic ischemic stroke after intra-arterial injection. Experimental Neurology 2010, 221:122-128.
23. Battistella V., de Freitas G.R., da Fonseca L.M., Mercante D., Gutfilen B., Goldenberg R.C., Dias J.V., Kasai-Brunswick T.H., Wajnberg E., Rosado-de-Castro P.H., Alves-Leon S.V., Mendez-Otero R., Andre C. Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke. Regenerative Medicine 2011, 6:45-52.
24. Becker W., Meller J. The role of nuclear medicine in infection and inflammation. Lancet Infectious Diseases 2001, 1:326-333.
25. Bhasin A., Padma Srivastava M.V., Mohanty S., Bhatia R., Kumaran S.S., Bose S. Stem cell therapy: a clinical trial of stroke. Clinical Neurology and Neurosurgery 2013, 115:1003-1008.
26. Bhasin A., Srivastava M.V., Kumaran S.S., Mohanty S., Bhatia R., Bose S., Gaikwad S., Garg A., Airan B. Autologous mesenchymal stem cells in chronic stroke. Cerebrovascular Diseases Extra 2011, 1:93-104.
27. Bible E., Dell'Acqua F., Solanky B., Balducci A., Crapo P.M., Badylak S.F., Ahrens E.T., Modo M. Non-invasive imaging of transplanted human neural stem cells and ECM scaffold remodeling in the stroke-damaged rat brain by (19)F- and diffusion-MRI. Biomaterials 2012, 33:2858-2871.
28. Blackwood K.J., Lewden B., Wells R.G., Sykes J., Stodilka R.Z., Wisenberg G., Prato F.S. In vivo SPECT quantification of transplanted cell survival after engraftment using (111)In-tropolone in infarcted canine myocardium. Journal of Nuclear Medicine 2009, 50:927-935.
29. Bliss T.M., Andres R.H., Steinberg G.K. Optimizing the success of cell transplantation therapy for stroke. Neurobiology of Disease 2010, 37:275-283.
30. Borlongan C.V., Hadman M., Sanberg C.D., Sanberg P.R. Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke 2004, 35:2385-2389.
31. Borlongan C.V., Kaneko Y., Maki M., Yu S.J., Ali M., Allickson J.G., Sanberg C.D., Kuzmin-Nichols N., Sanberg P.R. Menstrual blood cells display stem cell-like phenotypic markers and exert neuroprotection following transplantation in experimental stroke. Stem Cells and Development 2010, 19:439-452.
32. Buhnemann C., Scholz A., Bernreuther C., Malik C.Y., Braun H., Schachner M., Reymann K.G., Dihne M. Neuronal differentiation of transplanted embryonic stem cell-derived precursors in stroke lesions of adult rats. Brain 2006, 129:3238-3248.
33. Cai C., Teng L., Vu D., He J.Q., Guo Y., Li Q., Tang X.L., Rokosh G., Bhatnagar A., Bolli R. The heme oxygenase 1 inducer (CoPP) protects human cardiac stem cells against apoptosis through activation of the extracellular signal-regulated kinase (ERK)/NRF2 signaling pathway and cytokine release. Journal of Biological Chemistry 2012, 287:33720-33732.
34. Caiazzo M., Dell'Anno M.T., Dvoretskova E., Lazarevic D., Taverna S., Leo D., Sotnikova T.D., Menegon A., Roncaglia P., Colciago G., Russo G., Carninci P., Pezzoli G., Gainetdinov R.R., Gustincich S., Dityatev A., Broccoli V. Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature 2011, 476:224-227.
35. Chang D.J., Lee N., Choi C., Jeon I., Oh S.H., Shin D.A., Hwang T.S., Lee H.J., Kim S.U., Moon H., Hong K.S., Kang K.S., Song J. Therapeutic effect of BDNF-overexpressing human neural stem cells (HB1.F3.BDNF) in a rodent model of middle cerebral artery occlusion. Cell Transplantation 2013, 22:1441-1452.
36. Chang D.J., Lee N., Park I.H., Choi C., Jeon I., Kwon J., Oh S.H., Shin D.A., Do J.T., Lee D.R., Lee H., Moon H., Hong K.S., Daley G.Q., Song J. Therapeutic potential of human induced pluripotent stem cells in experimental stroke. Cell Transplantation 2013, 22:1427-1440.
37. Chen B., Gao X.Q., Yang C.X., Tan S.K., Sun Z.L., Yan N.H., Pang Y.G., Yuan M., Chen G.J., Xu G.T., Zhang K., Yuan Q.L. Neuroprotective effect of grafting GDNF gene-modified neural stem cells on cerebral ischemia in rats. Brain Research 2009, 1284:1-11.
38. Chen C., Cheng Y., Chen J. Transfection of Noggin in bone marrow stromal cells (BMSCs) enhances BMSC-induced functional outcome after stroke in rats. Journal of Neuroscience Research 2011, 89:1194-1202.
39. Chen C., Wang Y., Yang G.Y. Stem cell-mediated gene delivering for the treatment of cerebral ischemia: progress and prospectives. Current Drug Targets 2013, 14:81-89.
40. Chen J., Chopp M. Neurorestorative treatment of stroke: cell and pharmacological approaches. NeuroRx 2006, 3:466-473.
41. Chen J., Li Y., Katakowski M., Chen X., Wang L., Lu D., Lu M., Gautam S.C., Chopp M. Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. Journal of Neuroscience Research 2003, 73:778-786.
42. Chen J., Li Y., Wang L., Lu M., Zhang X., Chopp M. Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats. Journal of Neuroscience Research 2001, 189:49-57.
43. Chen J., Li Y., Wang L., Zhang Z., Lu D., Lu M., Chopp M. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 2001, 32:1005-1011.
44. Chen J., Sanberg P.R., Li Y., Wang L., Lu M., Willing A.E., Sanchez-Ramos J., Chopp M. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 2001, 32:2682-2688.
45. Chen J., Shehadah A., Pal A., Zacharek A., Cui X., Cui Y., Roberts C., Lu M., Zeitlin A., Hariri R., Chopp M. Neuroprotective effect of human placenta-derived cell treatment of stroke in rats. Cell Transplantation 2013, 22:871-879.
46. Chen J., Ye X., Yan T., Zhang C., Yang X.P., Cui X., Cui Y., Zacharek A., Roberts C., Liu X., Dai X., Lu M., Chopp M. Adverse effects of bone marrow stromal cell treatment of stroke in diabetic rats. Stroke 2011, 42:3551-3558.
47. Chen J., Zhang Z.G., Li Y., Wang L., Xu Y.X., Gautam S.C., Lu M., Zhu Z., Chopp M. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circulation Research 2003, 92:692-699.
48. Chen N., Newcomb J., Garbuzova-Davis S., Davis Sanberg C., Sanberg P.R., Willing A.E. Human umbilical cord blood cells have trophic effects on young and aging hippocampal neurons in vitro. Aging and Disease 2010, 1:173-190.
49. Chen S.H., Wang J.J., Chen C.H., Chang H.K., Lin M.T., Chang F.M., Chio C.C. Umbilical cord blood-derived CD34+ cells improve outcomes of traumatic brain injury in rats by stimulating angiogenesis and neurogenesis. Cell Transplantation 2013.
50. Chen S.J., Chang C.M., Tsai S.K., Chang Y.L., Chou S.J., Huang S.S., Tai L.K., Chen Y.C., Ku H.H., Li H.Y., Chiou S.H. Functional improvement of focal cerebral ischemia injury by subdural transplantation of induced pluripotent stem cells with fibrin glue. Stem Cells and Development 2010, 19:1757-1767.
51. Chen T.S., Lai R.C., Lee M.M., Choo A.B., Lee C.N., Lim S.K. Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs. Nucleic Acids Research 2010, 38:215-224.
52. Chen X., Katakowski M., Li Y., Lu D., Wang L., Zhang L., Chen J., Xu Y., Gautam S., Mahmood A., Chopp M. Human bone marrow stromal cell cultures conditioned by traumatic brain tissue extracts: growth factor production. Journal of Neuroscience Research 2002, 69:687-691.
53. Chen X., Li Y., Wang L., Katakowski M., Zhang L., Chen J., Xu Y., Gautam S.C., Chopp M. Ischemic rat brain extracts induce human marrow stromal cell growth factor production. Neuropathology 2002, 22:275-279.
54. Cho Y.J., Song H.S., Bhang S., Lee S., Kang B.G., Lee J.C., An J., Cha C.I., Nam D.H., Kim B.S., Joo K.M. Therapeutic effects of human adipose stem cell-conditioned medium on stroke. Journal of Neuroscience Research 2012, 90:1794-1802.
55. Chopp M., Li Y., Zhang Z.G. Mechanisms underlying improved recovery of neurological function after stroke in the rodent after treatment with neurorestorative cell-based therapies. Stroke 2009, 40:S143-S145.
56. Christopherson K.S., Ullian E.M., Stokes C.C., Mullowney C.E., Hell J.W., Agah A., Lawler J., Mosher D.F., Bornstein P., Barres B.A. Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell 2005, 120:421-433.
57. Chu K., Kim M., Park K.I., Jeong S.W., Park H.K., Jung K.H., Lee S.T., Kang L., Lee K., Park D.K., Kim S.U., Roh J.K. Human neural stem cells improve sensorimotor deficits in the adult rat brain with experimental focal ischemia. Brain Research 2004, 1016:145-153.
58. Chua J.Y., Pendharkar A.V., Wang N., Choi R., Andres R.H., Gaeta X., Zhang J., Moseley M.E., Guzman R. Intra-arterial injection of neural stem cells using a microneedle technique does not cause microembolic strokes. Journal of Cerebral Blood Flow and Metabolism 2011, 31:1263-1271.
59. Correa P.L., Mesquita C.T., Felix R.M., Azevedo J.C., Barbirato G.B., Falcao C.H., Gonzalez C., Mendonca M.L., Manfrim A., de Freitas G., Oliveira C.C., Silva D., Avila D., Borojevic R., Alves S., Oliveira A.C., Dohmann H.F. Assessment of intra-arterial injected autologous bone marrow mononuclear cell distribution by radioactive labeling in acute ischemic stroke. Clinical Nuclear Medicine 2007, 32:839-841.
60. Cui X., Chopp M., Zacharek A., Roberts C., Lu M., Savant-Bhonsale S., Chen J. Chemokine, vascular and therapeutic effects of combination simvastatin and BMSC treatment of stroke. Neurobiology of Disease 2009, 36:35-41.
61. Daadi M.M., Li Z., Arac A., Grueter B.A., Sofilos M., Malenka R.C., Wu J.C., Steinberg G.K. Molecular and magnetic resonance imaging of human embryonic stem cell-derived neural stem cell grafts in ischemic rat brain. Molecular Therapy 2009, 17:1282-1291.
62. Danielyan L., Schafer R., von Ameln-Mayerhofer A., Bernhard F., Verleysdonk S., Buadze M., Lourhmati A., Klopfer T., Schaumann F., Schmid B., Koehle C., Proksch B., Weissert R., Reichardt H.M., van den Brandt J., Buniatian G.H., Schwab M., Gleiter C.H., Frey W.H. Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease. Rejuvenation Research 2011, 14:3-16.
63. Danielyan L., Schafer R., von Ameln-Mayerhofer A., Buadze M., Geisler J., Klopfer T., Burkhardt U., Proksch B., Verleysdonk S., Ayturan M., Buniatian G.H., Gleiter C.H., Frey W.H. Intranasal delivery of cells to the brain. European Journal of Cell Biology 2009, 88:315-324.
64. Darsalia V., Kallur T., Kokaia Z. Survival, migration and neuronal differentiation of human fetal striatal and cortical neural stem cells grafted in stroke-damaged rat striatum. European Journal of Neuroscience 2007, 26:605-614.
65. Das R., Jahr H., van Osch G.J., Farrell E. The role of hypoxia in bone marrow-derived mesenchymal stem cells: considerations for regenerative medicine approaches. Tissue Engineering Part B: Reviews 2010, 16:159-168.
66. De Feo D., Merlini A., Laterza C., Martino G. Neural stem cell transplantation in central nervous system disorders: from cell replacement to neuroprotection. Current Opinion in Neurology 2012, 25:322-333.
67. Del Zoppo G.J., Saver J.L., Jauch E.C., Adams H.P. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke 2009, 40:2945-2948.
68. 99mTc-HMPAO-labeled human mesenchymal stem cells after stroke: in vivo imaging and biodistribution. Cell Transplantation 2009, 18:1369-1379.
69. Dhuria S.V., Hanson L.R., Frey W.H. Intranasal delivery to the central nervous system: mechanisms and experimental considerations. Journal of Pharmaceutical Sciences 2010, 99:1654-1673.
70. Ding J., Cheng Y., Gao S., Chen J. Effects of nerve growth factor and Noggin-modified bone marrow stromal cells on stroke in rats. Journal of Neuroscience Research 2011, 89:222-230.
71. Donega V., van Velthoven C.T., Nijboer C.H., van Bel F., Kas M.J., Kavelaars A., Heijnen C.J. Intranasal mesenchymal stem cell treatment for neonatal brain damage: long-term cognitive and sensorimotor improvement. PLoS ONE 2013, 8:e51253.
72. Eaves C.J., Cashman J.D., Kay R.J., Dougherty G.J., Otsuka T., Gaboury L.A., Hogge D.E., Lansdorp P.M., Eaves A.C., Humphries R.K. Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer. Blood 1991, 78:110-117.
73. Egashira Y., Sugitani S., Suzuki Y., Mishiro K., Tsuruma K., Shimazawa M., Yoshimura S., Iwama T., Hara H. The conditioned medium of murine and human adipose-derived stem cells exerts neuroprotective effects against experimental stroke model. Brain Research 2012, 1461:87-95.
74. Einstein O., Fainstein N., Vaknin I., Mizrachi-Kol R., Reihartz E., Grigoriadis N., Lavon I., Baniyash M., Lassmann H., Ben-Hur T. Neural precursors attenuate autoimmune encephalomyelitis by peripheral immunosuppression. Annals of Neurology 2007, 61:209-218.
75. Eiraku M., Watanabe K., Matsuo-Takasaki M., Kawada M., Yonemura S., Matsumura M., Wataya T., Nishiyama A., Muguruma K., Sasai Y. Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals. Cell Stem Cell 2008, 3:519-532.
76. Emborg M.E., Liu Y., Xi J., Zhang X., Yin Y., Lu J., Joers V., Swanson C., Holden J.E., Zhang S.C. Induced pluripotent stem cell-derived neural cells survive and mature in the nonhuman primate brain. Cell Reports 2013, 3:646-650.
77. Erdo F., Buhrle C., Blunk J., Hoehn M., Xia Y., Fleischmann B., Focking M., Kustermann E., Kolossov E., Hescheler J., Hossmann K.A., Trapp T. Host-dependent tumorigenesis of embryonic stem cell transplantation in experimental stroke. Journal of Cerebral Blood Flow and Metabolism 2003, 23:780-785.
78. Ergul A., Alhusban A., Fagan S.C. Angiogenesis: a harmonized target for recovery after stroke. Stroke 2012, 43:2270-2274.
79. Feigin V.L., Lawes C.M., Bennett D.A., Barker-Collo S.L., Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurology 2009, 8:355-369.
80. Fischer U.M., Harting M.T., Jimenez F., Monzon-Posadas W.O., Xue H., Savitz S.I., Laine G.A., Cox C.S. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells and Development 2009, 18:683-692.
81. Fisher M. New approaches to neuroprotective drug development. Stroke 2011, 42:S24-S27.
82. Fisher M., Feuerstein G., Howells D.W., Hurn P.D., Kent T.A., Savitz S.I., Lo E.H. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 2009, 40:2244-2250.
83. Fraichard A., Chassande O., Bilbaut G., Dehay C., Savatier P., Samarut J. In vitro differentiation of embryonic stem cells into glial cells and functional neurons. Journal of Cell Science 1995, 108:3181-3188.
84. Francis K.R., Wei L. Human embryonic stem cell neural differentiation and enhanced cell survival promoted by hypoxic preconditioning. Cell Death & Disease 2010, 1:e22.
85. Franco E.C., Cardoso M.M., Gouveia A., Pereira A., Gomes-Leal W. Modulation of microglial activation enhances neuroprotection and functional recovery derived from bone marrow mononuclear cell transplantation after cortical ischemia. Neuroscience Research 2012, 73:122-132.
86. Frenkel D., Solomon B. Filamentous phage as vector-mediated antibody delivery to the brain. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:5675-5679.
87. Friedrich M.A., Martins M.P., Araujo M.D., Klamt C., Vedolin L., Garicochea B., Raupp E.F., Sartori El Ammar J., Machado D.C., Costa J.C., Nogueira R.G., Rosado-de-Castro P.H., Mendez-Otero R., Freitas G.R. Intra-arterial infusion of autologous bone marrow mononuclear cells in patients with moderate to severe middle cerebral artery acute ischemic stroke. Cell Transplantation 2012, 21(Suppl. 1):S13-S21.
88. Fujimoto M., Hayashi H., Takagi Y., Hayase M., Marumo T., Gomi M., Nishimura M., Kataoka H., Takahashi J., Hashimoto N., Nozaki K., Miyamoto S. Transplantation of telencephalic neural progenitors induced from embryonic stem cells into subacute phase of focal cerebral ischemia. Laboratory Investigation 2012, 92:522-531.
89. Fukuchi Y., Nakajima H., Sugiyama D., Hirose I., Kitamura T., Tsuji K. Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells 2004, 22:649-658.
90. Ginsberg M.D. Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology 2008, 55:363-389.
91. Glover L.E., Tajiri N., Weinbren N.L., Ishikawa H., Shinozuka K., Kaneko Y., Watterson D.M., Borlongan C.V. A step-up approach for cell therapy in stroke: translational hurdles of bone marrow-derived stem cells. Translational Stroke Research 2012, 3:90-98.
92. Go A.S., Mozaffarian D., Roger V.L., Benjamin E.J., Berry J.D., Borden W.B., Bravata D.M., Dai S., Ford E.S., Fox C.S., Franco S., Fullerton H.J., Gillespie C., Hailpern S.M., Heit J.A., Howard V.J., Huffman M.D., Kissela B.M., Kittner S.J., Lackland D.T., Lichtman J.H., Lisabeth L.D., Magid D., Marcus G.M., Marelli A., Matchar D.B., McGuire D.K., Mohler E.R., Moy C.S., Mussolino M.E., Nichol G., Paynter N.P., Schreiner P.J., Sorlie P.D., Stein J., Turan T.N., Virani S.S., Wong N.D., Woo D., Turner M.B. Heart disease and stroke statistics - 2013 update: a report from the American Heart Association. Circulation 2013, 127:e6-e245.
93. Goldman S.A., Chen Z. Perivascular instruction of cell genesis and fate in the adult brain. Nature Neuroscience 2011, 14:1382-1389.
94. Gomi M., Takagi Y., Morizane A., Doi D., Nishimura M., Miyamoto S., Takahashi J. Functional recovery of the murine brain ischemia model using human induced pluripotent stem cell-derived telencephalic progenitors. Brain Research 2012, 1459:52-60.
95. Gornicka-Pawlak el B., Janowski M., Habich A., Jablonska A., Drela K., Kozlowska H., Lukomska B., Sypecka J., Domanska-Janik K. Systemic treatment of focal brain injury in the rat by human umbilical cord blood cells being at different level of neural commitment. Acta Neurobiologiae Experimentalis 2011, 71:46-64.
96. Greenberg D.A., Jin K. Vascular endothelial growth factors (VEGFs) and stroke. Cellular and Molecular Life Sciences 2013, 70:1753-1761.
97. Grotta J.C., Jacobs T.P., Koroshetz W.J., Moskowitz M.A. Stroke program review group: an interim report. Stroke 2008, 39:1364-1370.
98. Guzman R., Bliss T., De Los Angeles A., Moseley M., Palmer T., Steinberg G. Neural progenitor cells transplanted into the uninjured brain undergo targeted migration after stroke onset. Journal of Neuroscience Research 2008, 86:873-882.
99. Guzman R., Choi R., Gera A., De Los Angeles A., Andres R.H., Steinberg G.K. Intravascular cell replacement therapy for stroke. Neurosurgical Focus 2008, 24:E15.
100. Guzman R., De Los Angeles A., Cheshier S., Choi R., Hoang S., Liauw J., Schaar B., Steinberg G. Intracarotid injection of fluorescence activated cell-sorted CD49d-positive neural stem cells improves targeted cell delivery and behavior after stroke in a mouse stroke model. Stroke 2008, 39:1300-1306.
101. Guzman R., Uchida N., Bliss T.M., He D., Christopherson K.K., Stellwagen D., Capela A., Greve J., Malenka R.C., Moseley M.E., Palmer T.D., Steinberg G.K. Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:10211-10216.
102. Han I.K., Kim M.Y., Byun H.M., Hwang T.S., Kim J.M., Hwang K.W., Park T.G., Jung W.W., Chun T., Jeong G.J., Oh Y.K. Enhanced brain targeting efficiency of intranasally administered plasmid DNA: an alternative route for brain gene therapy. Journal of Molecular Medicine 2007, 85:75-83.
103. Hayashi J., Takagi Y., Fukuda H., Imazato T., Nishimura M., Fujimoto M., Takahashi J., Hashimoto N., Nozaki K. Primate embryonic stem cell-derived neuronal progenitors transplanted into ischemic brain. Journal of Cerebral Blood Flow and Metabolism 2006, 26:906-914.
104. Hayashi T., Noshita N., Sugawara T., Chan P.H. Temporal profile of angiogenesis and expression of related genes in the brain after ischemia. Journal of Cerebral Blood Flow and Metabolism 2003, 23:166-180.
105. He A., Jiang Y., Gui C., Sun Y., Li J., Wang J.A. The antiapoptotic effect of mesenchymal stem cell transplantation on ischemic myocardium is enhanced by anoxic preconditioning. Canadian Journal of Cardiology 2009, 25:353-358.
106. Hedlund M., Stenqvist A.C., Nagaeva O., Kjellberg L., Wulff M., Baranov V., Mincheva-Nilsson L. Human placenta expresses and secretes NKG2D ligands via exosomes that down-modulate the cognate receptor expression: evidence for immunosuppressive function. Journal of Immunology 2009, 183:340-351.
107. Henning R.J., Abu-Ali H., Balis J.U., Morgan M.B., Willing A.E., Sanberg P.R. Human umbilical cord blood mononuclear cells for the treatment of acute myocardial infarction. Cell Transplantation 2004, 13:729-739.
108. Henning R.J., Burgos J.D., Vasko M., Alvarado F., Sanberg C.D., Sanberg P.R., Morgan M.B. Human cord blood cells and myocardial infarction: effect of dose and route of administration on infarct size. Cell Transplantation 2007, 16:907-917.
109. Hess D.C., Borlongan C.V. Stem cells and neurological diseases. Cell Proliferation 2008, 41(Suppl. 1):94-114.
110. Hicks A.U., Lappalainen R.S., Narkilahti S., Suuronen R., Corbett D., Sivenius J., Hovatta O., Jolkkonen J. Transplantation of human embryonic stem cell-derived neural precursor cells and enriched environment after cortical stroke in rats: cell survival and functional recovery. European Journal of Neuroscience 2009, 29:562-574.
111. Hirko A.C., Dallasen R., Jomura S., Xu Y. Modulation of inflammatory responses after global ischemia by transplanted umbilical cord matrix stem cells. Stem Cells 2008, 26:2893-2901.
112. Hoehn M., Kustermann E., Blunk J., Wiedermann D., Trapp T., Wecker S., Focking M., Arnold H., Hescheler J., Fleischmann B.K., Schwindt W., Buhrle C. Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:16267-16272.
113. Hoehn M., Wiedermann D., Justicia C., Ramos-Cabrer P., Kruttwig K., Farr T., Himmelreich U. Cell tracking using magnetic resonance imaging. Journal of Physiology 2007, 584:25-30.
114. Honmou O., Houkin K., Matsunaga T., Niitsu Y., Ishiai S., Onodera R., Waxman S.G., Kocsis J.D. Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain 2011, 134:1790-1807.
115. Honmou O., Onodera R., Sasaki M., Waxman S.G., Kocsis J.D. Mesenchymal stem cells: therapeutic outlook for stroke. Trends in Molecular Medicine 2012, 18:292-297.
116. Horita Y., Honmou O., Harada K., Houkin K., Hamada H., Kocsis J.D. Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat. Journal of Neuroscience Research 2006, 84:1495-1504.
117. Hu X., Wei L., Taylor T.M., Wei J., Zhou X., Wang J.A., Yu S.P. Hypoxic preconditioning enhances bone marrow mesenchymal stem cell migration via Kv2.1 channel and FAK activation. American Journal of Physiology Cell Physiology 2011, 301:C362-C372.
118. Huang W., Mo X., Qin C., Zheng J., Liang Z., Zhang C. Transplantation of differentiated bone marrow stromal cells promotes motor functional recovery in rats with stroke. Neurological Research 2013, 35:320-328.
119. Idris N.M., Ashraf M., Ahmed R.P., Shujia J., Haider K.H. Activation of IL-11/STAT3 pathway in preconditioned human skeletal myoblasts blocks apoptotic cascade under oxidant stress. Regenerative Medicine 2012, 7:47-57.
120. Igura K., Zhang X., Takahashi K., Mitsuru A., Yamaguchi S., Takashi T.A. Isolation and characterization of mesenchymal progenitor cells from chorionic villi of human placenta. Cytotherapy 2004, 6:543-553.
121. Ii M., Nishimura H., Iwakura A., Wecker A., Eaton E., Asahara T., Losordo D.W. Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported" nitric oxide synthase activity. Circulation 2005, 111:1114-1120.
122. Ii M., Nishimura H., Sekiguchi H., Kamei N., Yokoyama A., Horii M., Asahara T. Concurrent vasculogenesis and neurogenesis from adult neural stem cells. Circulation Research 2009, 105:860-868.
123. Inoue T., Sugiyama M., Hattori H., Wakita H., Wakabayashi T., Ueda M. Stem cells from human exfoliated deciduous tooth-derived conditioned medium enhance recovery of focal cerebral ischemia in rats. Tissue Engineering Part A 2013, 19:24-29.
124. Ishibashi S., Sakaguchi M., Kuroiwa T., Yamasaki M., Kanemura Y., Shizuko I., Shimazaki T., Onodera M., Okano H., Mizusawa H. Human neural stem/progenitor cells, expanded in long-term neurosphere culture, promote functional recovery after focal ischemia in Mongolian gerbils. Journal of Neuroscience Research 2004, 78:215-223.
125. Ito D., Okano H., Suzuki N. Accelerating progress in induced pluripotent stem cell research for neurological diseases. Annals of Neurology 2012, 72:167-174.
126. Jaiswal J.K., Simon S.M. Imaging single events at the cell membrane. Nature Chemical Biology 2007, 3:92-98.
127. Jat P.S., Noble M.D., Ataliotis P., Tanaka Y., Yannoutsos N., Larsen L., Kioussis D. Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse. Proceedings of the National Academy of Sciences of the United States of America 1991, 88:5096-5100.
128. Jendelova P., Herynek V., DeCroos J., Glogarova K., Andersson B., Hajek M., Sykova E. Imaging the fate of implanted bone marrow stromal cells labeled with superparamagnetic nanoparticles. Magnetic Resonance in Medicine 2003, 50:767-776.
129. Jensen M.B., Yan H., Krishnaney-Davison R., Al Sawaf A., Zhang S.C. Survival and differentiation of transplanted neural stem cells derived from human induced pluripotent stem cells in a rat stroke model. Journal of Stroke and Cerebrovascular Diseases 2013, 22:304-308.
130. Jiang B., Xiao W., Shi Y., Liu M., Xiao X. Heat shock pretreatment inhibited the release of Smac/DIABLO from mitochondria and apoptosis induced by hydrogen peroxide in cardiomyocytes and C2C12 myogenic cells. Cell Stress & Chaperones 2005, 10:252-262.
131. Jiang M., Lv L., Ji H., Yang X., Zhu W., Cai L., Gu X., Chai C., Huang S., Sun J., Dong Q. Induction of pluripotent stem cells transplantation therapy for ischemic stroke. Molecular and Cellular Biochemistry 2011, 354:67-75.
132. Jiang Y., Wei N., Zhu J., Zhai D., Wu L., Chen M., Xu G., Liu X. A new approach with less damage: intranasal delivery of tetracycline-inducible replication-defective herpes simplex virus type-1 vector to brain. Neuroscience 2012, 201:96-104.
133. Jiang Y., Zhu J., Xu G., Liu X. Intranasal delivery of stem cells to the brain. Expert Opinion on Drug Delivery 2011, 8:623-632.
134. Jiang Y., Zhu W., Zhu J., Wu L., Xu G., Liu X. Feasibility of delivering mesenchymal stem cells via catheter to the proximal end of lesion artery in patients with stroke in the territory of middle cerebral artery. Cell Transplantation 2012.
135. Jin K., Mao X., Xie L., Greenberg R.B., Peng B., Moore A., Greenberg M.B., Greenberg D.A. Delayed transplantation of human neural precursor cells improves outcome from focal cerebral ischemia in aged rats. Aging Cell 2010, 9:1076-1083.
136. Jin K., Minami M., Lan J.Q., Mao X.O., Batteur S., Simon R.P., Greenberg D.A. Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:4710-4715.
137. Jin K., Xie L., Mao X., Greenberg M.B., Moore A., Peng B., Greenberg R.B., Greenberg D.A. Effect of human neural precursor cell transplantation on endogenous neurogenesis after focal cerebral ischemia in the rat. Brain Research 2011, 1374:56-62.
138. Johnston S.C., Mendis S., Mathers C.D. Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling. Lancet Neurology 2009, 8:345-354.
139. Kamiya N., Ueda M., Igarashi H., Nishiyama Y., Suda S., Inaba T., Katayama Y. Intra-arterial transplantation of bone marrow mononuclear cells immediately after reperfusion decreases brain injury after focal ischemia in rats. Life Sciences 2008, 83:433-437.
140. Kang S.K., Lee D.H., Bae Y.C., Kim H.K., Baik S.Y., Jung J.S. Improvement of neurological deficits by intracerebral transplantation of human adipose tissue-derived stromal cells after cerebral ischemia in rats. Experimental Neurology 2003, 183:355-366.
141. Kawabori M., Kuroda S., Sugiyama T., Ito M., Shichinohe H., Houkin K., Kuge Y., Tamaki N. Intracerebral, but not intravenous, transplantation of bone marrow stromal cells enhances functional recovery in rat cerebral infarct: an optical imaging study. Neuropathology 2012, 32:217-226.
142. Kawai H., Yamashita T., Ohta Y., Deguchi K., Nagotani S., Zhang X., Ikeda Y., Matsuura T., Abe K. Tridermal tumorigenesis of induced pluripotent stem cells transplanted in ischemic brain. Journal of Cerebral Blood Flow and Metabolism 2010, 30:1487-1493.
143. Kelly S., Bliss T.M., Shah A.K., Sun G.H., Ma M., Foo W.C., Masel J., Yenari M.A., Weissman I.L., Uchida N., Palmer T., Steinberg G.K. Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:11839-11844.
144. Kim D.E., Schellingerhout D., Ishii K., Shah K., Weissleder R. Imaging of stem cell recruitment to ischemic infarcts in a murine model. Stroke 2004, 35:952-957.
145. Kim J.H., Oh A.Y., Choi Y.M., Ku S.Y., Kim Y.Y., Lee N.J., Sepac A., Bosnjak Z.J. Isoflurane decreases death of human embryonic stem cell-derived, transcriptional marker Nkx2.5(+) cardiac progenitor cells. Acta Anaesthesiologica Scandinavica 2011, 55:1124-1131.
146. Kim S.S., Yoo S.W., Park T.S., Ahn S.C., Jeong H.S., Kim J.W., Chang D.Y., Cho K.G., Kim S.U., Huh Y., Lee J.E., Lee S.Y., Lee Y.D., Suh-Kim H. Neural induction with neurogenin1 increases the therapeutic effects of mesenchymal stem cells in the ischemic brain. Stem Cells 2008, 26:2217-2228.
147. Kinnaird T., Stabile E., Burnett M.S., Epstein S.E. Bone marrow-derived cells for enhancing collateral development: mechanisms, animal data, and initial clinical experiences. Circulation Research 2004, 95:354-363.
148. Kinnaird T., Stabile E., Burnett M.S., Lee C.W., Barr S., Fuchs S., Epstein S.E. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circulation Research 2004, 94:678-685.
149. Kobayashi T., Ahlenius H., Thored P., Kobayashi R., Kokaia Z., Lindvall O. Intracerebral infusion of glial cell line-derived neurotrophic factor promotes striatal neurogenesis after stroke in adult rats. Stroke 2006, 37:2361-2367.
150. Kocsis J.D., Honmou O. Bone marrow stem cells in experimental stroke. Progress in Brain Research 2012, 201:79-98.
151. Koh W., Sheng C.T., Tan B., Lee Q.Y., Kuznetsov V., Kiang L.S., Tanavde V. Analysis of deep sequencing microRNA expression profile from human embryonic stem cells derived mesenchymal stem cells reveals possible role of let-7 microRNA family in downstream targeting of hepatic nuclear factor 4 alpha. BMC Genomics 2010, 11(Suppl. 1):S6.
152. Kokaia Z., Martino G., Schwartz M., Lindvall O. Cross-talk between neural stem cells and immune cells: the key to better brain repair?. Nature Neuroscience 2012, 15:1078-1087.
153. Kondo-Nakamura M., Shintani-Ishida K., Uemura K., Yoshida K. Brief exposure to carbon monoxide preconditions cardiomyogenic cells against apoptosis in ischemia-reperfusion. Biochemical and Biophysical Research Communications 2010, 393:449-454.
154. Kondziolka D., Steinberg G.K., Wechsler L., Meltzer C.C., Elder E., Gebel J., Decesare S., Jovin T., Zafonte R., Lebowitz J., Flickinger J.C., Tong D., Marks M.P., Jamieson C., Luu D., Bell-Stephens T., Teraoka J. Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. Journal of Neurosurgery 2005, 103:38-45.
155. Kondziolka D., Wechsler L., Goldstein S., Meltzer C., Thulborn K.R., Gebel J., Jannetta P., DeCesare S., Elder E.M., McGrogan M., Reitman M.A., Bynum L. Transplantation of cultured human neuronal cells for patients with stroke. Neurology 2000, 55:565-569.
156. Kozlowska H., Jablonka J., Janowski M., Jurga M., Kossut M., Domanska-Janik K. Transplantation of a novel human cord blood-derived neural-like stem cell line in a rat model of cortical infarct. Stem Cells and Development 2007, 16:481-488.
157. Kranz A., Wagner D.C., Kamprad M., Scholz M., Schmidt U.R., Nitzsche F., Aberman Z., Emmrich F., Riegelsberger U.M., Boltze J. Transplantation of placenta-derived mesenchymal stromal cells upon experimental stroke in rats. Brain Research 2010, 1315:128-136.
158. Krupinski J., Kaluza J., Kumar P., Kumar S., Wang J.M. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke 1994, 25:1794-1798.
159. Kurozumi K., Nakamura K., Tamiya T., Kawano Y., Ishii K., Kobune M., Hirai S., Uchida H., Sasaki K., Ito Y., Kato K., Honmou O., Houkin K., Date I., Hamada H. Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Molecular Therapy 2005, 11:96-104.
160. Kurozumi K., Nakamura K., Tamiya T., Kawano Y., Kobune M., Hirai S., Uchida H., Sasaki K., Ito Y., Kato K., Honmou O., Houkin K., Date I., Hamada H. BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. Molecular Therapy 2004, 9:189-197.
161. Lai R.C., Arslan F., Lee M.M., Sze N.S., Choo A., Chen T.S., Salto-Tellez M., Timmers L., Lee C.N., El Oakley R.M., Pasterkamp G., de Kleijn D.P., Lim S.K. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Research 2010, 4:214-222.
162. Lappalainen R.S., Narkilahti S., Huhtala T., Liimatainen T., Suuronen T., Narvanen A., Suuronen R., Hovatta O., Jolkkonen J. The SPECT imaging shows the accumulation of neural progenitor cells into internal organs after systemic administration in middle cerebral artery occlusion rats. Neuroscience Letters 2008, 440:246-250.
163. Lee H.J., Kim K.S., Kim E.J., Choi H.B., Lee K.H., Park I.H., Ko Y., Jeong S.W., Kim S.U. Brain transplantation of immortalized human neural stem cells promotes functional recovery in mouse intracerebral hemorrhage stroke model. Stem Cells 2007, 25:1204-1212.
164. Lee H.J., Kim K.S., Park I.H., Kim S.U. Human neural stem cells over-expressing VEGF provide neuroprotection, angiogenesis and functional recovery in mouse stroke model. PLoS ONE 2007, 2:e156.
165. Lee J.S., Hong J.M., Moon G.J., Lee P.H., Ahn Y.H., Bang O.Y. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells 2010, 28:1099-1106.
166. Lee S.H., Lumelsky N., Studer L., Auerbach J.M., McKay R.D. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nature Biotechnology 2000, 18:675-679.
167. Lee S.T., Chu K., Jung K.H., Kim S.J., Kim D.H., Kang K.M., Hong N.H., Kim J.H., Ban J.J., Park H.K., Kim S.U., Park C.G., Lee S.K., Kim M., Roh J.K. Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke. Brain 2008, 131:616-629.
168. Leonardo C.C., Hall A.A., Collier L.A., Ajmo C.T., Willing A.E., Pennypacker K.R. Human umbilical cord blood cell therapy blocks the morphological change and recruitment of CD11b-expressing, isolectin-binding proinflammatory cells after middle cerebral artery occlusion. Journal of Neuroscience Research 2010, 88:1213-1222.
169. Leong W.K., Henshall T.L., Arthur A., Kremer K.L., Lewis M.D., Helps S.C., Field J., Hamilton-Bruce M.A., Warming S., Manavis J., Vink R., Gronthos S., Koblar S.A. Human adult dental pulp stem cells enhance poststroke functional recovery through non-neural replacement mechanisms. Stem Cells Translational Medicine 2012, 1:177-187.
170. Li F., Ambrosini G., Chu E.Y., Plescia J., Tognin S., Marchisio P.C., Altieri D.C. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998, 396:580-584.
171. Li J.H., Zhang N., Wang J.A. Improved anti-apoptotic and anti-remodeling potency of bone marrow mesenchymal stem cells by anoxic pre-conditioning in diabetic cardiomyopathy. Journal of Endocrinological Investigation 2008, 31:103-110.
172. Li L., Jiang Q., Ding G., Zhang L., Zhang Z.G., Li Q., Panda S., Lu M., Ewing J.R., Chopp M. Effects of administration route on migration and distribution of neural progenitor cells transplanted into rats with focal cerebral ischemia, an MRI study. Journal of Cerebral Blood Flow and Metabolism 2010, 30:653-662.
173. Li L., Zeng H., Chen J.X. Apelin-13 increases myocardial progenitor cells and improves repair postmyocardial infarction. American Journal of Physiology Heart and Circulatory Physiology 2012, 303:H605-H618.
174. Li Y., Chen J., Chen X.G., Wang L., Gautam S.C., Xu Y.X., Katakowski M., Zhang L.J., Lu M., Janakiraman N., Chopp M. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 2002, 59:514-523.
175. Li Y., Chen J., Chopp M. Adult bone marrow transplantation after stroke in adult rats. Cell Transplantation 2001, 10:31-40.
176. Li Y., Chen J., Wang L., Lu M., Chopp M. Treatment of stroke in rat with intracarotid administration of marrow stromal cells. Neurology 2001, 56:1666-1672.
177. Li Y., Chen J., Zhang C.L., Wang L., Lu D., Katakowski M., Gao Q., Shen L.H., Zhang J., Lu M., Chopp M. Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia 2005, 49:407-417.
178. Li Y., Chopp M., Chen J., Wang L., Gautam S.C., Xu Y.X., Zhang Z. Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice. Journal of Cerebral Blood Flow and Metabolism 2000, 20:1311-1319.
179. Li Y., Lu Z., Keogh C.L., Yu S.P., Wei L. Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice. Journal of Cerebral Blood Flow and Metabolism 2007, 27:1043-1054.
180. Li Y., McIntosh K., Chen J., Zhang C., Gao Q., Borneman J., Raginski K., Mitchell J., Shen L., Zhang J., Lu D., Chopp M. Allogeneic bone marrow stromal cells promote glial-axonal remodeling without immunologic sensitization after stroke in rats. Experimental Neurology 2006, 198:313-325.
181. Lim J.Y., Jeong C.H., Jun J.A., Kim S.M., Ryu C.H., Hou Y., Oh W., Chang J.W., Jeun S.S. Therapeutic effects of human umbilical cord blood-derived mesenchymal stem cells after intrathecal administration by lumbar puncture in a rat model of cerebral ischemia. Stem Cell Research & Therapy 2011, 2:38.
182. Liu H., Honmou O., Harada K., Nakamura K., Houkin K., Hamada H., Kocsis J.D. Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia. Brain 2006, 129:2734-2745.
183. Liu N., Deguchi K., Yamashita T., Liu W., Ikeda Y., Abe K. Intracerebral transplantation of bone marrow stromal cells ameliorates tissue plasminogen activator-induced brain damage after cerebral ischemia in mice detected by in vivo and ex vivo optical imaging. Journal of Neuroscience Research 2012, 90:2086-2093.
184. Liu N., Zhang Y., Fan L., Yuan M., Du H., Cheng R., Liu D., Lin F. Effects of transplantation with bone marrow-derived mesenchymal stem cells modified by Survivin on experimental stroke in rats. Journal of Translational Medicine 2011, 9:105.
185. Liu X. Clinical trials of intranasal delivery for treating neurological disorders - a critical review. Expert Opinion on Drug Delivery 2011, 8:1681-1690.
186. Liu X. Beyond the time window of intravenous thrombolysis: standing by or by stenting. Interventional Neurology 2012, 1:3-15.
187. Liu Y.P., Seckin H., Izci Y., Du Z.W., Yan Y.P., Baskaya M.K. Neuroprotective effects of mesenchymal stem cells derived from human embryonic stem cells in transient focal cerebral ischemia in rats. Journal of Cerebral Blood Flow and Metabolism 2009, 29:780-791.
188. Liu Z., Li Y., Qu R., Shen L., Gao Q., Zhang X., Lu M., Savant-Bhonsale S., Borneman J., Chopp M. Axonal sprouting into the denervated spinal cord and synaptic and postsynaptic protein expression in the spinal cord after transplantation of bone marrow stromal cell in stroke rats. Brain Research 2007, 1149:172-180.
189. Liu Z., Li Y., Zhang L., Xin H., Cui Y., Hanson L.R., Frey W.H., Chopp M. Subacute intranasal administration of tissue plasminogen activator increases functional recovery and axonal remodeling after stroke in rats. Neurobiology of Disease 2012, 45:804-809.
190. Lu D., Sanberg P.R., Mahmood A., Li Y., Wang L., Sanchez-Ramos J., Chopp M. Intravenous administration of human umbilical cord blood reduces neurological deficit in the rat after traumatic brain injury. Cell Transplantation 2002, 11:275-281.
191. Lu G., Ashraf M., Haider K.H. Insulin-like growth factor-1 preconditioning accentuates intrinsic survival mechanism in stem cells to resist ischemic injury by orchestrating protein kinase Calpha-ERK1/2 activation. Antioxidants & Redox Signaling 2012, 16:217-227.
192. Lu T., Jiang Y., Zhou Z., Yue X., Wei N., Chen Z., Ma M., Xu G., Liu X. Intranasal ginsenoside Rb1 targets the brain and ameliorates cerebral ischemia/reperfusion injury in rats. Biological & Pharmaceutical Bulletin 2011, 34:1319-1324.
193. Ma Y.P., Ma M.M., Ge S., Guo R.B., Zhang H.J., Frey W.H., Xu G.L., Liu X.F. Intranasally delivered TGF-beta1 enters brain and regulates gene expressions of its receptors in rats. Brain Research Bulletin 2007, 74:271-277.
194. Majumdar M.K., Thiede M.A., Mosca J.D., Moorman M., Gerson S.L. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. Journal of Cellular Physiology 1998, 176:57-66.
195. Makinen S., Kekarainen T., Nystedt J., Liimatainen T., Huhtala T., Narvanen A., Laine J., Jolkkonen J. Human umbilical cord blood cells do not improve sensorimotor or cognitive outcome following transient middle cerebral artery occlusion in rats. Brain Research 2006, 1123:207-215.
196. Manley N.C., Steinberg G.K. Tracking stem cells for cellular therapy in stroke. Current Pharmaceutical Design 2012, 18:3685-3693.
197. Martino G., Franklin R.J., Baron Van Evercooren A., Kerr D.A. Stem cell transplantation in multiple sclerosis: current status and future prospects. Nature Reviews Neurology 2010, 6:247-255.
198. Martino G., Pluchino S. The therapeutic potential of neural stem cells. Nature Reviews Neuroscience 2006, 7:395-406.
199. Martino G., Pluchino S., Bonfanti L., Schwartz M. Brain regeneration in physiology and pathology: the immune signature driving therapeutic plasticity of neural stem cells. Physiological Reviews 2011, 91:1281-1304.
200. Matsuda-Hashii Y., Takai K., Ohta H., Fujisaki H., Tokimasa S., Osugi Y., Ozono K., Matsumoto K., Nakamura T., Hara J. Hepatocyte growth factor plays roles in the induction and autocrine maintenance of bone marrow stromal cell IL-11, SDF-1 alpha, and stem cell factor. Experimental Hematology 2004, 32:955-961.
201. McGuckin C.P., Jurga M., Miller A.M., Sarnowska A., Wiedner M., Boyle N.T., Lynch M.A., Jablonska A., Drela K., Lukomska B., Domanska-Janik K., Kenner L., Moriggl R., Degoul O., Perruisseau-Carrier C., Forraz N. Ischemic brain injury: a consortium analysis of key factors involved in mesenchymal stem cell-mediated inflammatory reduction. Archives of Biochemistry and Biophysics 2013, 534:88-97.
202. Mehler M.F., Rozental R., Dougherty M., Spray D.C., Kessler J.A. Cytokine regulation of neuronal differentiation of hippocampal progenitor cells. Nature 1993, 362:62-65.
203. Meng S., Cao J., Wang L., Zhou Q., Li Y., Shen C., Zhang X., Wang C. MicroRNA 107 partly inhibits endothelial progenitor cells differentiation via HIF-1beta. PLoS ONE 2012, 7:e40323.
204. Michalet X., Pinaud F.F., Bentolila L.A., Tsay J.M., Doose S., Li J.J., Sundaresan G., Wu A.M., Gambhir S.S., Weiss S. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005, 307:538-544.
205. Miki Y., Nonoguchi N., Ikeda N., Coffin R.S., Kuroiwa T., Miyatake S. Vascular endothelial growth factor gene-transferred bone marrow stromal cells engineered with a herpes simplex virus type 1 vector can improve neurological deficits and reduce infarction volume in rat brain ischemia. Neurosurgery 2007, 61:586-594. (discussion 594-585).
206. Mine Y., Tatarishvili J., Oki K., Monni E., Kokaia Z., Lindvall O. Grafted human neural stem cells enhance several steps of endogenous neurogenesis and improve behavioral recovery after middle cerebral artery occlusion in rats. Neurobiology of Disease 2013, 52:191-203.
207. Mir O., Savitz S.I. Stem cell therapy in stroke treatment: is it a viable option?. Expert Review of Neurotherapeutics 2013, 13:119-121.
208. Misra V., Ritchie M.M., Stone L.L., Low W.C., Janardhan V. Stem cell therapy in ischemic stroke: role of IV and intra-arterial therapy. Neurology 2012, 79:S207-S212.
209. Mitkari B., Kerkela E., Nystedt J., Korhonen M., Mikkonen V., Huhtala T., Jolkkonen J. Intra-arterial infusion of human bone marrow-derived mesenchymal stem cells results in transient localization in the brain after cerebral ischemia in rats. Experimental Neurology 2013, 239:158-162.
210. Miura K., Okada Y., Aoi T., Okada A., Takahashi K., Okita K., Nakagawa M., Koyanagi M., Tanabe K., Ohnuki M., Ogawa D., Ikeda E., Okano H., Yamanaka S. Variation in the safety of induced pluripotent stem cell lines. Nature Biotechnology 2009, 27:743-745.
211. Modo M., Beech J.S., Meade T.J., Williams S.C., Price J. A chronic 1 year assessment of MRI contrast agent-labelled neural stem cell transplants in stroke. Neuroimage 2009, 47(Suppl. 2):T133-T142.
212. Modo M., Cash D., Mellodew K., Williams S.C., Fraser S.E., Meade T.J., Price J., Hodges H. Tracking transplanted stem cell migration using bifunctional, contrast agent-enhanced, magnetic resonance imaging. Neuroimage 2002, 17:803-811.
213. Modo M., Mellodew K., Cash D., Fraser S.E., Meade T.J., Price J., Williams S.C. Mapping transplanted stem cell migration after a stroke: a serial, in vivo magnetic resonance imaging study. Neuroimage 2004, 21:311-317.
214. Modo M., Rezaie P., Heuschling P., Patel S., Male D.K., Hodges H. Transplantation of neural stem cells in a rat model of stroke: assessment of short-term graft survival and acute host immunological response. Brain Research 2002, 958:70-82.
215. Modo M., Stroemer R.P., Tang E., Patel S., Hodges H. Effects of implantation site of stem cell grafts on behavioral recovery from stroke damage. Stroke 2002, 33:2270-2278.
216. Moniche F., Gonzalez A., Gonzalez-Marcos J.R., Carmona M., Pinero P., Espigado I., Garcia-Solis D., Cayuela A., Montaner J., Boada C., Rosell A., Jimenez M.D., Mayol A., Gil-Peralta A. Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial. Stroke 2012, 43:2242-2244.
217. Morgado J.M., Pratas R., Laranjeira P., Henriques A., Crespo I., Regateiro F., Paiva A. The phenotypical and functional characteristics of cord blood monocytes and CD14(-/low)/CD16(+) dendritic cells can be relevant to the development of cellular immune responses after transplantation. Transplant Immunology 2008, 19:55-63.
218. Nagai N., Kawao N., Okada K., Okumoto K., Teramura T., Ueshima S., Umemura K., Matsuo O. Systemic transplantation of embryonic stem cells accelerates brain lesion decrease and angiogenesis. Neuroreport 2010, 21:575-579.
219. Nakano-Doi A., Nakagomi T., Fujikawa M., Nakagomi N., Kubo S., Lu S., Yoshikawa H., Soma T., Taguchi A., Matsuyama T. Bone marrow mononuclear cells promote proliferation of endogenous neural stem cells through vascular niches after cerebral infarction. Stem Cells 2010, 28:1292-1302.
220. Neuhoff S., Moers J., Rieks M., Grunwald T., Jensen A., Dermietzel R., Meier C. Proliferation, differentiation, and cytokine secretion of human umbilical cord blood-derived mononuclear cells in vitro. Experimental Hematology 2007, 35:1119-1131.
221. Niagara M.I., Haider H., Jiang S., Ashraf M. Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart. Circulation Research 2007, 100:545-555.
222. Nikolic W.V., Hou H., Town T., Zhu Y., Giunta B., Sanberg C.D., Zeng J., Luo D., Ehrhart J., Mori T., Sanberg P.R., Tan J. Peripherally administered human umbilical cord blood cells reduce parenchymal and vascular beta-amyloid deposits in Alzheimer mice. Stem Cells and Development 2008, 17:423-439.
223. Nishishita T., Ouchi K., Zhang X., Inoue M., Inazawa T., Yoshiura K., Kuwabara K., Nakaoka T., Watanabe N., Igura K., Takahashi T.A., Yamashita N. A potential pro-angiogenic cell therapy with human placenta-derived mesenchymal cells. Biochemical and Biophysical Research Communications 2004, 325:24-31.
224. Nystedt J., Makinen S., Laine J., Jolkkonen J. Human cord blood CD34+ cells and behavioral recovery following focal cerebral ischemia in rats. Acta Neurobiologiae Experimentalis 2006, 66:293-300.
225. O'Collins V.E., Macleod M.R., Donnan G.A., Horky L.L., van der Worp B.H., Howells D.W. 1,026 experimental treatments in acute stroke. Annals of Neurology 2006, 59:467-477.
226. Ogle M.E., Gu X., Espinera A.R., Wei L. Inhibition of prolyl hydroxylases by dimethyloxaloylglycine after stroke reduces ischemic brain injury and requires hypoxia inducible factor-1alpha. Neurobiology of Disease 2012, 45:733-742.
227. Ohab J.J., Fleming S., Blesch A., Carmichael S.T. A neurovascular niche for neurogenesis after stroke. Journal of Neuroscience 2006, 26:13007-13016.
228. Okazaki T., Magaki T., Takeda M., Kajiwara Y., Hanaya R., Sugiyama K., Arita K., Nishimura M., Kato Y., Kurisu K. Intravenous administration of bone marrow stromal cells increases survivin and Bcl-2 protein expression and improves sensorimotor function following ischemia in rats. Neuroscience Letters 2008, 430:109-114.
229. Oki K., Tatarishvili J., Wood J., Koch P., Wattananit S., Mine Y., Monni E., Tornero D., Ahlenius H., Ladewig J., Brustle O., Lindvall O., Kokaia Z. Human-induced pluripotent stem cells form functional neurons and improve recovery after grafting in stroke-damaged brain. Stem Cells 2012, 30:1120-1133.
230. Onda T., Honmou O., Harada K., Houkin K., Hamada H., Kocsis J.D. Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism 2008, 28:329-340.
231. Ou Y., Yu S., Kaneko Y., Tajiri N., Bae E.C., Chheda S.H., Stahl C.E., Yang T., Fang L., Hu K., Borlongan C.V., Yu G. Intravenous infusion of GDNF gene-modified human umbilical cord blood CD34+ cells protects against cerebral ischemic injury in spontaneously hypertensive rats. Brain Research 2010, 1366:217-225.
232. Oyamada N., Itoh H., Sone M., Yamahara K., Miyashita K., Park K., Taura D., Inuzuka M., Sonoyama T., Tsujimoto H., Fukunaga Y., Tamura N., Nakao K. Transplantation of vascular cells derived from human embryonic stem cells contributes to vascular regeneration after stroke in mice. Journal of Translational Medicine 2008, 6:54.
233. Pang Z.P., Yang N., Vierbuchen T., Ostermeier A., Fuentes D.R., Yang T.Q., Citri A., Sebastiano V., Marro S., Sudhof T.C., Wernig M. Induction of human neuronal cells by defined transcription factors. Nature 2011, 476:220-223.
234. Park K.I., Himes B.T., Stieg P.E., Tessler A., Fischer I., Snyder E.Y. Neural stem cells may be uniquely suited for combined gene therapy and cell replacement: evidence from engraftment of neurotrophin-3-expressing stem cells in hypoxic-ischemic brain injury. Experimental Neurology 2006, 199:179-190.
235. Park S., Koh S.E., Maeng S., Lee W.D., Lim J., Lee Y.J. Neural progenitors generated from the mesenchymal stem cells of first-trimester human placenta matured in the hypoxic-ischemic rat brain and mediated restoration of locomotor activity. Placenta 2011, 32:269-276.
236. Parody R., Martino R., Rovira M., Vazquez L., Vazquez M.J., de la Camara R., Blazquez C., Fernandez-Aviles F., Carreras E., Salavert M., Jarque I., Martin C., Martinez F., Lopez J., Torres A., Sierra J., Sanz G.F. Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation. Biology of Blood and Marrow Transplantation 2006, 12:734-748.
237. Pasha Z., Wang Y., Sheikh R., Zhang D., Zhao T., Ashraf M. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovascular Research 2008, 77:134-142.
238. Patkar S., Tate R., Modo M., Plevin R., Carswell H.V. Conditionally immortalised neural stem cells promote functional recovery and brain plasticity after transient focal cerebral ischaemia in mice. Stem Cell Research 2012, 8:14-25.
239. Payen E., Leboulch P. Advances in stem cell transplantation and gene therapy in the beta-hemoglobinopathies. American Society of Hematology Education Program 2012, 2012:276-283.
240. Pendharkar A.V., Chua J.Y., Andres R.H., Wang N., Gaeta X., Wang H., De A., Choi R., Chen S., Rutt B.K., Gambhir S.S., Guzman R. Biodistribution of neural stem cells after intravascular therapy for hypoxic-ischemia. Stroke 2010, 41:2064-2070.
241. Peterson K.M., Aly A., Lerman A., Lerman L.O., Rodriguez-Porcel M. Improved survival of mesenchymal stromal cell after hypoxia preconditioning: role of oxidative stress. Life Sciences 2011, 88:65-73.
242. Pluchino S., Gritti A., Blezer E., Amadio S., Brambilla E., Borsellino G., Cossetti C., Del Carro U., Comi G., t Hart B., Vescovi A., Martino G. Human neural stem cells ameliorate autoimmune encephalomyelitis in non-human primates. Annals of Neurology 2009, 66:343-354.
243. Pluchino S., Zanotti L., Rossi B., Brambilla E., Ottoboni L., Salani G., Martinello M., Cattalini A., Bergami A., Furlan R., Comi G., Constantin G., Martino G. Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 2005, 436:266-271.
244. Polentes J., Jendelova P., Cailleret M., Braun H., Romanyuk N., Tropel P., Brenot M., Itier V., Seminatore C., Baldauf K., Turnovcova K., Jirak D., Teletin M., Come J., Tournois J., Reymann K., Sykova E., Viville S., Onteniente B. Human induced pluripotent stem cells improve stroke outcome and reduce secondary degeneration in the recipient brain. Cell Transplantation 2012, 21:2587-2602.
245. Polezhaev L.V., Alexandrova M.A. Transplantation of embryonic brain tissue into the brain of adult rats after hypoxic hypoxia. Journal für Hirnforschung 1984, 25:99-106.
246. Polezhaev L.V., Alexandrova M.A., Vitvitsky V.N., Girman S.V., Golovina I.L. Morphological, biochemical and physiological changes in brain nervous tissue of adult intact and hypoxia-subjected rats after transplantation of embryonic nervous tissue. Journal für Hirnforschung 1985, 26:281-289.
247. Pollock K., Stroemer P., Patel S., Stevanato L., Hope A., Miljan E., Dong Z., Hodges H., Price J., Sinden J.D. A conditionally immortal clonal stem cell line from human cortical neuroepithelium for the treatment of ischemic stroke. Experimental Neurology 2006, 199:143-155.
248. Ponte A.L., Marais E., Gallay N., Langonne A., Delorme B., Herault O., Charbord P., Domenech J. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 2007, 25:1737-1745.
249. Portmann-Lanz C.B., Schoebedein A., Huber A., Sager R., Malek A., Holzgreve W., Surbek D.V. Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration. American Journal of Obstetrics and Gynecology 2006, 194:664-673.
250. Prasad K., Mohanty S., Bhatia R., Srivastava M.V., Garg A., Srivastava A., Goyal V., Tripathi M., Kumar A., Bal C., Vij A., Mishra N.K. Autologous intravenous bone marrow mononuclear cell therapy for patients with subacute ischaemic stroke: a pilot study. Indian Journal of Medical Research 2012, 136:221-228.
251. Prather W.R., Toren A., Meiron M., Ofir R., Tschope C., Horwitz E.M. The role of placental-derived adherent stromal cell (PLX-PAD) in the treatment of critical limb ischemia. Cytotherapy 2009, 11:427-434.
252. Raber J., Fan Y., Matsumori Y., Liu Z., Weinstein P.R., Fike J.R., Liu J. Irradiation attenuates neurogenesis and exacerbates ischemia-induced deficits. Annals of Neurology 2004, 55:381-389.
253. Rabinovich S.S., Seledtsov V.I., Banul N.V., Poveshchenko O.V., Senyukov V.V., Astrakov S.V., Samarin D.M., Taraban V.Y. Cell therapy of brain stroke. Bulletin of Experimental Biology and Medicine 2005, 139:126-128.
254. Reitz M., Demestre M., Sedlacik J., Meissner H., Fiehler J., Kim S.U., Westphal M., Schmidt N.O. Intranasal delivery of neural stem/progenitor cells: a noninvasive passage to target intracerebral glioma. Stem Cells Translational Medicine 2012, 1:866-873.
255. Reubinoff B.E., Pera M.F., Fong C.Y., Trounson A., Bongso A. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nature Biotechnology 2000, 18:399-404.
256. Riess P., Zhang C., Saatman K.E., Laurer H.L., Longhi L.G., Raghupathi R., Lenzlinger P.M., Lifshitz J., Boockvar J., Neugebauer E., Snyder E.Y., McIntosh T.K. Transplanted neural stem cells survive, differentiate, and improve neurological motor function after experimental traumatic brain injury. Neurosurgery 2002, 51:1043-1052. (discussion 1052-1044).
257. Rocha V., Gluckman E. Clinical use of umbilical cord blood hematopoietic stem cells. Biology of Blood and Marrow Transplantation 2006, 12:34-41.
258. Roitberg B.Z., Mangubat E., Chen E.Y., Sugaya K., Thulborn K.R., Kordower J.H., Pawar A., Konecny T., Emborg M.E. Survival and early differentiation of human neural stem cells transplanted in a nonhuman primate model of stroke. Journal of Neurosurgery 2006, 105:96-102.
259. Rosado-de-Castro P.H., Schmidt F.da.R., Battistella V., Lopes de Souza S.A., Gutfilen B., Goldenberg R.C., Kasai-Brunswick T.H., Vairo L., Silva R.M., Wajnberg E., Alvarenga Americano do Brasil P.E., Gasparetto E.L., Maiolino A., Alves-Leon S.V., Andre C., Mendez-Otero R., Rodriguez de Freitas G., Barbosa da Fonseca L.M. Biodistribution of bone marrow mononuclear cells after intra-arterial or intravenous transplantation in subacute stroke patients. Regenerative Medicine 2013, 8:145-155.
260. Rosenblum S., Wang N., Smith T.N., Pendharkar A.V., Chua J.Y., Birk H., Guzman R. Timing of intra-arterial neural stem cell transplantation after hypoxia-ischemia influences cell engraftment, survival, and differentiation. Stroke 2012, 43:1624-1631.
261. Roura S., Pujal J.M., Bayes-Genis A. Umbilical cord blood for cardiovascular cell therapy: from promise to fact. Annals of the New York Academy of Sciences 2012, 1254:66-70.
262. Rowe D.D., Leonardo C.C., Hall A.A., Shahaduzzaman M.D., Collier L.A., Willing A.E., Pennypacker K.R. Cord blood administration induces oligodendrocyte survival through alterations in gene expression. Brain Research 2010, 17:172-188.
263. Rowe D.D., Leonardo C.C., Recio J.A., Collier L.A., Willing A.E., Pennypacker K.R. Human umbilical cord blood cells protect oligodendrocytes from brain ischemia through Akt signal transduction. Journal of Biological Chemistry 2012, 287:4177-4187.
264. Rubinstein P., Carrier C., Scaradavou A., Kurtzberg J., Adamson J., Migliaccio A.R., Berkowitz R.L., Cabbad M., Dobrila N.L., Taylor P.E., Rosenfield R.E., Stevens C.E. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. New England Journal of Medicine 1998, 339:1565-1577.
265. Sahota P., Savitz S.I. Investigational therapies for ischemic stroke: neuroprotection and neurorecovery. Neurotherapeutics 2011, 8:434-451.
266. Sakata H., Niizuma K., Wakai T., Narasimhan P., Maier C.M., Chan P.H. Neural stem cells genetically modified to overexpress Cu/Zn-superoxide dismutase enhance amelioration of ischemic stroke in mice. Stroke 2012, 43:2423-2429.
267. Sanberg P.R., Eve D.J., Metcalf C., Borlongan C.V. Advantages and challenges of alternative sources of adult-derived stem cells for brain repair in stroke. Progress in brain research 2012, 201:99-117.
268. Sanchez-Ramos J., Song S., Cardozo-Pelaez F., Hazzi C., Stedeford T., Willing A., Freeman T.B., Saporta S., Janssen W., Patel N., Cooper D.R., Sanberg P.R. Adult bone marrow stromal cells differentiate into neural cells in vitro. Experimental Neurology 2000, 164:247-256.
269. Savitz S.I., Chopp M., Deans R., Carmichael S.T., Phinney D., Wechsler L. Stem cell therapy as an emerging paradigm for stroke (STEPS) II. Stroke 2011, 42:825-829.
270. Savitz S.I., Dinsmore J., Wu J., Henderson G.V., Stieg P., Caplan L.R. Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study. Cerebrovascular Diseases 2005, 20:101-107.
271. Savitz S.I., Misra V., Kasam M., Juneja H., Cox C.S., Alderman S., Aisiku I., Kar S., Gee A., Grotta J.C. Intravenous autologous bone marrow mononuclear cells for ischemic stroke. Annals of Neurology 2011, 70:59-69.
272. Savitz S.I., Rosenbaum D.M., Dinsmore J.H., Wechsler L.R., Caplan L.R. Cell transplantation for stroke. Annals of Neurology 2002, 52:266-275.
273. Schoeberlein A., Mueller M., Reinhart U., Sager R., Messerli M., Surbek D.V. Homing of placenta-derived mesenchymal stem cells after perinatal intracerebral transplantation in a rat model. American Journal of Obstetrics and Gynecology 2011, 205:277.e1-277.e6.
274. Seyed Jafari S.S., Ali Aghaei A., Asadi-Shekaari M., Nematollahi-Mahani S.N., Sheibani V. Investigating the effects of adult neural stem cell transplantation by lumbar puncture in transient cerebral ischemia. Neuroscience Letters 2011, 495:1-5.
275. Shapiro E.M., Sharer K., Skrtic S., Koretsky A.P. In vivo detection of single cells by MRI. Magnetic Resonance in Medicine 2006, 55:242-249.
276. Sheikh A.M., Nagai A., Wakabayashi K., Narantuya D., Kobayashi S., Yamaguchi S., Kim S.U. Mesenchymal stem cell transplantation modulates neuroinflammation in focal cerebral ischemia: contribution of fractalkine and IL-5. Neurobiology of Disease 2011, 41:717-724.
277. Shen C.C., Lin C.H., Yang Y.C., Chiao M.T., Cheng W.Y., Ko J.L. Intravenous implanted neural stem cells migrate to injury site, reduce infarct volume, and improve behavior after cerebral ischemia. Current Neurovascular Research 2010, 7:167-179.
278. Shen L.H., Li Y., Chen J., Cui Y., Zhang C., Kapke A., Lu M., Savant-Bhonsale S., Chopp M. One-year follow-up after bone marrow stromal cell treatment in middle-aged female rats with stroke. Stroke 2007, 38:2150-2156.
279. Shen L.H., Li Y., Chen J., Zhang J., Vanguri P., Borneman J., Chopp M. Intracarotid transplantation of bone marrow stromal cells increases axon-myelin remodeling after stroke. Neuroscience 2006, 137:393-399.
280. Shen L.H., Li Y., Chopp M. Astrocytic endogenous glial cell derived neurotrophic factor production is enhanced by bone marrow stromal cell transplantation in the ischemic boundary zone after stroke in adult rats. Glia 2010, 58:1074-1081.
281. Shen L.H., Xin H., Li Y., Zhang R.L., Cui Y., Zhang L., Lu M., Zhang Z.G., Chopp M. Endogenous tissue plasminogen activator mediates bone marrow stromal cell-induced neurite remodeling after stroke in mice. Stroke 2011, 42:459-464.
282. Shichinohe H., Kuroda S., Lee J.B., Nishimura G., Yano S., Seki T., Ikeda J., Tamura M., Iwasaki Y. In vivo tracking of bone marrow stromal cells transplanted into mice cerebral infarct by fluorescence optical imaging. Brain Research Brain Research Protocols 2004, 13:166-175.
283. Shin S., Sung B.J., Cho Y.S., Kim H.J., Ha N.C., Hwang J.I., Chung C.W., Jung Y.K., Oh B.H. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry 2001, 40:1117-1123.
284. Shyu W.C., Lin S.Z., Chiang M.F., Su C.Y., Li H. Intracerebral peripheral blood stem cell (CD34+) implantation induces neuroplasticity by enhancing beta1 integrin-mediated angiogenesis in chronic stroke rats. Journal of Neuroscience 2006, 26:3444-3453.
285. Sideri A., Neokleous N., Brunet De La Grange P., Guerton B., Le Bousse Kerdilles M.C., Uzan G., Peste-Tsilimidos C., Gluckman E. An overview of the progress on double umbilical cord blood transplantation. Haematologica 2011, 96:1213-1220.
286. Smith E.J., Stroemer R.P., Gorenkova N., Nakajima M., Crum W.R., Tang E., Stevanato L., Sinden J.D., Modo M. Implantation site and lesion topology determine efficacy of a human neural stem cell line in a rat model of chronic stroke. Stem Cells 2012, 30:785-796.
287. Smith H.K., Gavins F.N. The potential of stem cell therapy for stroke: is PISCES the sign?. FASEB Journal 2012, 26:2239-2252.
288. Song M., Mohamad O., Gu X., Wei L., Yu S.P. Restoration of intracortical and thalamocortical circuits after transplantation of bone marrow mesenchymal stem cells into the ischemic brain of mice. Cell Transplantation 2012.
289. Stenderup K., Justesen J., Clausen C., Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 2003, 33:919-926.
290. Stephan R.P., Reilly C.R., Witte P.L. Impaired ability of bone marrow stromal cells to support B-lymphopoiesis with age. Blood 1998, 91:75-88.
291. Stroemer P., Patel S., Hope A., Oliveira C., Pollock K., Sinden J. The neural stem cell line CTX0E03 promotes behavioral recovery and endogenous neurogenesis after experimental stroke in a dose-dependent fashion. Neurorehabilitation and Neural Repair 2009, 23:895-909.
292. Stubbs S.L., Hsiao S.T., Peshavariya H.M., Lim S.Y., Dusting G.J., Dilley R.J. Hypoxic preconditioning enhances survival of human adipose-derived stem cells and conditions endothelial cells in vitro. Stem Cells and Development 2012, 21:1887-1896.
293. Suarez-Monteagudo C., Hernandez-Ramirez P., Alvarez-Gonzalez L., Garcia-Maeso I., de la Cuetara-Bernal K., Castillo-Diaz L., Bringas-Vega M.L., Martinez-Aching G., Morales-Chacon L.M., Baez-Martin M.M., Sanchez-Catasus C., Carballo-Barreda M., Rodriguez-Rojas R., Gomez-Fernandez L., Alberti-Amador E., Macias-Abraham C., Balea E.D., Rosales L.C., Del Valle Perez L., Ferrer B.B., Gonzalez R.M., Bergado J.A. Autologous bone marrow stem cell neurotransplantation in stroke patients. An open study. Restorative Neurology and Neuroscience 2009, 27:151-161.
294. Sugiyama T., Kuroda S., Osanai T., Shichinohe H., Kuge Y., Ito M., Kawabori M., Iwasaki Y. Near-infrared fluorescence labeling allows noninvasive tracking of bone marrow stromal cells transplanted into rat infarct brain. Neurosurgery 2011, 68:1036-1047. (discussion 1047).
295. Sutton E.J., Henning T.D., Pichler B.J., Bremer C., Daldrup-Link H.E. Cell tracking with optical imaging. European Radiology 2008, 18:2021-2032.
296. Szabolcs P., Niedzwiecki D. Immune reconstitution after unrelated cord blood transplantation. Cytotherapy 2007, 9:111-122.
297. Tae-Hoon L., Yoon-Seok L. Transplantation of mouse embryonic stem cell after middle cerebral artery occlusion. Acta Cirúrgica Brasileira 2012, 27:333-339.
298. Taguchi A., Soma T., Tanaka H., Kanda T., Nishimura H., Yoshikawa H., Tsukamoto Y., Iso H., Fujimori Y., Stern D.M., Naritomi H., Matsuyama T. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. Journal of Clinical Investigation 2004, 114:330-338.
299. Takagi Y., Nishimura M., Morizane A., Takahashi J., Nozaki K., Hayashi J., Hashimoto N. Survival and differentiation of neural progenitor cells derived from embryonic stem cells and transplanted into ischemic brain. Journal of Neurosurgery 2005, 103:304-310.
300. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
301. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
302. Takahashi K., Yasuhara T., Shingo T., Muraoka K., Kameda M., Takeuchi A., Yano A., Kurozumi K., Agari T., Miyoshi Y., Kinugasa K., Date I. Embryonic neural stem cells transplanted in middle cerebral artery occlusion model of rats demonstrated potent therapeutic effects, compared to adult neural stem cells. Brain Research 2008, 1234:172-182.
303. Takahashi S., Ooi J., Tomonari A., Konuma T., Tsukada N., Oiwa-Monna M., Fukuno K., Uchiyama M., Takasugi K., Iseki T., Tojo A., Yamaguchi T., Asano S. Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen. Blood 2007, 109:1322-1330.
304. Tang Y.L., Zhao Q., Qin X., Shen L., Cheng L., Ge J., Phillips M.I. Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. Annals of Thoracic Surgery 2005, 80:229-236. (discussion 236-227).
305. Tate C.C., Fonck C., McGrogan M., Case C.C. Human mesenchymal stromal cells and their derivative, SB623 cells, rescue neural cells via trophic support following in vitro ischemia. Cell Transplantation 2010, 19:973-984.
306. The STEPS Participants Stem Cell Therapies as an Emerging Paradigm in Stroke (STEPS): bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke. Stroke 2009, 40:510-515.
307. Theus M.H., Wei L., Cui L., Francis K., Hu X., Keogh C., Yu S.P. In vitro hypoxic preconditioning of embryonic stem cells as a strategy of promoting cell survival and functional benefits after transplantation into the ischemic rat brain. Experimental Neurology 2008, 210:656-670.
308. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
309. Tilkorn D.J., Davies E.M., Keramidaris E., Dingle A.M., Gerrand Y.W., Taylor C.J., Han X.L., Palmer J.A., Penington A.J., Mitchell C.A., Morrison W.A., Dusting G.J., Mitchell G.M. The in vitro preconditioning of myoblasts to enhance subsequent survival in an in vivo tissue engineering chamber model. Biomaterials 2012, 33:3868-3879.
310. Toda H., Takahashi J., Iwakami N., Kimura T., Hoki S., Mozumi-Kitamura K., Ono S., Hashimoto N. Grafting neural stem cells improved the impaired spatial recognition in ischemic rats. Neuroscience Letters 2001, 316:9-12.
311. Tohill M., Mantovani C., Wiberg M., Terenghi G. Rat bone marrow mesenchymal stem cells express glial markers and stimulate nerve regeneration. Neuroscience Letters 2004, 362:200-203.
312. Toyama K., Honmou O., Harada K., Suzuki J., Houkin K., Hamada H., Kocsis J.D. Therapeutic benefits of angiogenetic gene-modified human mesenchymal stem cells after cerebral ischemia. Experimental Neurology 2009, 216:47-55.
313. Tymianski M. Can molecular and cellular neuroprotection be translated into therapies for patients? Yes, but not the way we tried it before. Stroke 2010, 41:S87-S90.
314. Valable S., Montaner J., Bellail A., Berezowski V., Brillault J., Cecchelli R., Divoux D., Mackenzie E.T., Bernaudin M., Roussel S., Petit E. VEGF-induced BBB permeability is associated with an MMP-9 activity increase in cerebral ischemia: both effects decreased by Ang-1. Journal of Cerebral Blood Flow and Metabolism 2005, 25:1491-1504.
315. Valadi H., Ekstrom K., Bossios A., Sjostrand M., Lee J.J., Lotvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biology 2007, 9:654-659.
316. van Velthoven C.T., Kavelaars A., Heijnen C.J. Mesenchymal stem cells as a treatment for neonatal ischemic brain damage. Pediatric Research 2012, 71:474-481.
317. van Velthoven C.T., Kavelaars A., van Bel F., Heijnen C.J. Repeated mesenchymal stem cell treatment after neonatal hypoxia-ischemia has distinct effects on formation and maturation of new neurons and oligodendrocytes leading to restoration of damage, corticospinal motor tract activity, and sensorimotor function. Journal of Neuroscience 2010, 30:9603-9611.
318. van Velthoven C.T., Sheldon R.A., Kavelaars A., Derugin N., Vexler Z.S., Willemen H.L., Maas M., Heijnen C.J., Ferriero D.M. Mesenchymal stem cell transplantation attenuates brain injury after neonatal stroke. Stroke 2013, 44:1426-1432.
319. van Velthoven C.T., van de Looij Y., Kavelaars A., Zijlstra J., van Bel F., Huppi P.S., Sizonenko S., Heijnen C.J. Mesenchymal stem cells restore cortical rewiring after neonatal ischemia in mice. Annals of Neurology 2012, 71:785-796.
320. Vandeputte C., Thomas D., Dresselaers T., Crabbe A., Verfaillie C., Baekelandt V., Van Laere K., Himmelreich U. Characterization of the inflammatory response in a photothrombotic stroke model by MRI: implications for stem cell transplantation. Molecular Imaging and Biology 2011, 13:663-671.
321. Veizovic T., Beech J.S., Stroemer R.P., Watson W.P., Hodges H. Resolution of stroke deficits following contralateral grafts of conditionally immortal neuroepithelial stem cells. Stroke 2001, 32:1012-1019.
322. Vendrame M., Cassady J., Newcomb J., Butler T., Pennypacker K.R., Zigova T., Sanberg C.D., Sanberg P.R., Willing A.E. Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke 2004, 35:2390-2395.
323. Vendrame M., Gemma C., de Mesquita D., Collier L., Bickford P.C., Sanberg C.D., Sanberg P.R., Pennypacker K.R., Willing A.E. Anti-inflammatory effects of human cord blood cells in a rat model of stroke. Stem Cells and Development 2005, 14:595-604.
324. Vlassov A.V., Magdaleno S., Setterquist R., Conrad R. Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochimica et Biophysica Acta 2012, 1820:940-948.
325. Walczak P., Zhang J., Gilad A.A., Kedziorek D.A., Ruiz-Cabello J., Young R.G., Pittenger M.F., van Zijl P.C., Huang J., Bulte J.W. Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke 2008, 39:1569-1574.
326. Wang J., Chao F., Han F., Zhang G., Xi Q., Li J., Jiang H., Yu G., Tian M., Zhang H. PET demonstrates functional recovery after transplantation of induced pluripotent stem cells in a rat model of cerebral ischemic injury. Journal of Nuclear Medicine 2013, 54:785-792.
327. Wang J.A., He A., Hu X., Jiang Y., Sun Y., Jiang J., Gui C., Wang Y., Chen H. Anoxic preconditioning: a way to enhance the cardioprotection of mesenchymal stem cells. International Journal of Cardiology 2009, 133:410-412.
328. Wang Y., Xu F., Zhang C., Lei D., Tang Y., Xu H., Zhang Z., Lu H., Du X., Yang G.Y. High MR sensitive fluorescent magnetite nanocluster for stem cell tracking in ischemic mouse brain. Nanomedicine 2011, 7:1009-1019.
329. Warrier S., Haridas N., Bhonde R. Inherent propensity of amnion-derived mesenchymal stem cells towards endothelial lineage: vascularization from an avascular tissue. Placenta 2012, 33:850-858.
330. Wei L., Cui L., Snider B.J., Rivkin M., Yu S.S., Lee C.S., Adams L.D., Gottlieb D.I., Johnson E.M., Yu S.P., Choi D.W. Transplantation of embryonic stem cells overexpressing Bcl-2 promotes functional recovery after transient cerebral ischemia. Neurobiology of Disease 2005, 19:183-193.
331. Wei L., Fraser J.L., Lu Z.Y., Hu X., Yu S.P. Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats. Neurobiology of Disease 2012, 46:635-645.
332. Wei N., Yu S.P., Gu X., Taylor T.M., Song D., Liu X.F., Wei L. Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice. Cell Transplantation 2013, 22:977-991.
333. Wei X., Du Z., Zhao L., Feng D., Wei G., He Y., Tan J., Lee W.H., Hampel H., Dodel R., Johnstone B.H., March K.L., Farlow M.R., Du Y. IFATS collection: the conditioned media of adipose stromal cells protect against hypoxia-ischemia-induced brain damage in neonatal rats. Stem Cells 2009, 27:478-488.
334. Welling M.M., Duijvestein M., Signore A., van der Weerd L. In vivo biodistribution of stem cells using molecular nuclear medicine imaging. Journal of Cellular Physiology 2011, 226:1444-1452.
335. Wichterle H., Lieberam I., Porter J.A., Jessell T.M. Directed differentiation of embryonic stem cells into motor neurons. Cell 2002, 110:385-397.
336. Williams R.W., Herrup K. The control of neuron number. Annual Review of Neuroscience 1988, 11:423-453.
337. Wong A.M., Hodges H., Horsburgh K. Neural stem cell grafts reduce the extent of neuronal damage in a mouse model of global ischaemia. Brain Research 2005, 1063:140-150.
338. Wu Y., Chen L., Scott P.G., Tredget E.E. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 2007, 25:2648-2659.
339. Xie X., Sun A., Zhu W., Huang Z., Hu X., Jia J., Zou Y., Ge J. Transplantation of mesenchymal stem cells preconditioned with hydrogen sulfide enhances repair of myocardial infarction in rats. Tohoku Journal of Experimental Medicine 2012, 226:29-36.
340. Xin H., Li Y., Buller B., Katakowski M., Zhang Y., Wang X., Shang X., Zhang Z.G., Chopp M. Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth. Stem Cells 2012, 30:1556-1564.
341. Xin H., Li Y., Liu Z., Wang X., Shang X., Cui Y., Gang Zhang Z., Chopp M. Mir-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles. Stem Cells 2013.
342. Xin H., Li Y., Shen L.H., Liu X., Wang X., Zhang J., Pourabdollah-Nejad D.S., Zhang C., Zhang L., Jiang H., Zhang Z.G., Chopp M. Increasing tPA activity in astrocytes induced by multipotent mesenchymal stromal cells facilitate neurite outgrowth after stroke in the mouse. PLoS ONE 2010, 5:e9027.
343. Yamagata M., Yamamoto A., Kako E., Kaneko N., Matsubara K., Sakai K., Sawamoto K., Ueda M. Human dental pulp-derived stem cells protect against hypoxic-ischemic brain injury in neonatal mice. Stroke 2013, 44:551-554.
344. Yamashita T., Kawai H., Tian F., Ohta Y., Abe K. Tumorigenic development of induced pluripotent stem cells in ischemic mouse brain. Cell Transplantation 2011, 20:883-891.
345. Yan F., Yao Y., Chen L., Li Y., Sheng Z., Ma G. Hypoxic preconditioning improves survival of cardiac progenitor cells: role of stromal cell derived factor-1alpha-CXCR4 axis. PLoS ONE 2012, 7:e37948.
346. Yanagisawa D., Qi M., Kim D.H., Kitamura Y., Inden M., Tsuchiya D., Takata K., Taniguchi T., Yoshimoto K., Shimohama S., Akaike A., Sumi S., Inoue K. Improvement of focal ischemia-induced rat dopaminergic dysfunction by striatal transplantation of mouse embryonic stem cells. Neuroscience Letters 2006, 407:74-79.
347. Yang M., Baranov E., Moossa A.R., Penman S., Hoffman R.M. Visualizing gene expression by whole-body fluorescence imaging. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:12278-12282.
348. Yang T., Tsang K.S., Poon W.S., Ng H.K. Neurotrophism of bone marrow stromal cells to embryonic stem cells: noncontact induction and transplantation to a mouse ischemic stroke model. Cell Transplantation 2009, 18:391-404.
349. Yao Y., Zhang F., Wang L., Zhang G., Wang Z., Chen J., Gao X. Lipopolysaccharide preconditioning enhances the efficacy of mesenchymal stem cells transplantation in a rat model of acute myocardial infarction. Journal of Biomedical Science 2009, 16:74.
350. Yarygin K.N., Kholodenko I.V., Konieva A.A., Burunova V.V., Tairova R.T., Gubsky L.V., Cheglakov I.B., Pirogov Y.A., Yarygin V.N., Skvortsova V.I. Mechanisms of positive effects of transplantation of human placental mesenchymal stem cells on recovery of rats after experimental ischemic stroke. Bulletin of Experimental Biology and Medicine 2009, 148:862-868.
351. Yasuhara T., Hara K., Maki M., Xu L., Yu G., Ali M.M., Masuda T., Yu S.J., Bae E.K., Hayashi T., Matsukawa N., Kaneko Y., Kuzmin-Nichols N., Ellovitch S., Cruz E.L., Klasko S.K., Sanberg C.D., Sanberg P.R., Borlongan C.V. Mannitol facilitates neurotrophic factor up-regulation and behavioural recovery in neonatal hypoxic-ischaemic rats with human umbilical cord blood grafts. Journal of Cellular and Molecular Medicine 2010, 14:914-921.
352. Ye R., Kong X., Yang Q., Zhang Y., Han J., Li P., Xiong L., Zhao G. Ginsenoside Rd in experimental stroke: superior neuroprotective efficacy with a wide therapeutic window. Neurotherapeutics 2011, 8:515-525.
353. Ye R., Yang Q., Kong X., Li N., Zhang Y., Han J., Xiong L., Liu X., Zhao G. Sevoflurane preconditioning improves mitochondrial function and long-term neurologic sequelae after transient cerebral ischemia: role of mitochondrial permeability transition. Critical Care Medicine 2012, 40:2685-2693.
354. Ye R., Zhao G., Liu X. Ginsenoside Rd for acute ischemic stroke: translating from bench to bedside. Expert Review of Neurotherapeutics 2013, 13:603-613.
355. Yoo K.H., Jang I.K., Lee M.W., Kim H.E., Yang M.S., Eom Y., Lee J.E., Kim Y.J., Yang S.K., Jung H.L., Sung K.W., Kim C.W., Koo H.H. Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. Cellular Immunology 2009, 259:150-156.
356. Yu S.P., Wei Z., Wei L. Preconditioning strategy in stem cell transplantation therapy. Translational Stroke Research 2013, 4:76-88.
357. Yu X., Chen D., Zhang Y., Wu X., Huang Z., Zhou H., Zhang Z. Overexpression of CXCR4 in mesenchymal stem cells promotes migration, neuroprotection and angiogenesis in a rat model of stroke. Journal of The Neurological Sciences 2012, 316:141-149.
358. Zacharek A., Chen J., Cui X., Li A., Li Y., Roberts C., Feng Y., Gao Q., Chopp M. Angiopoietin1/Tie2 and VEGF/Flk1 induced by MSC treatment amplifies angiogenesis and vascular stabilization after stroke. Journal of Cerebral Blood Flow and Metabolism 2007, 27:1684-1691.
359. Zawadzka M., Lukasiuk K., Machaj E.K., Pojda Z., Kaminska B. Lack of migration and neurological benefits after infusion of umbilical cord blood cells in ischemic brain injury. Acta Neurobiologiae Experimentalis 2009, 69:46-51.
360. Zemani F., Silvestre J.S., Fauvel-Lafeve F., Bruel A., Vilar J., Bieche I., Laurendeau I., Galy-Fauroux I., Fischer A.M., Boisson-Vidal C. Ex vivo priming of endothelial progenitor cells with SDF-1 before transplantation could increase their proangiogenic potential. Arteriosclerosis, Thrombosis, and Vascular Biology 2008, 28:644-650.
361. Zhang J., Chen G.H., Wang Y.W., Zhao J., Duan H.F., Liao L.M., Zhang X.Z., Chen Y.D., Chen H. Hydrogen peroxide preconditioning enhances the therapeutic efficacy of Wharton's Jelly mesenchymal stem cells after myocardial infarction. Chinese Medical Journal 2012, 125:3472-3478.
362. Zhang L., Li Y., Romanko M., Kramer B.C., Gosiewska A., Chopp M., Hong K. Different routes of administration of human umbilical tissue-derived cells improve functional recovery in the rat after focal cerebral ischemia. Brain Research 2012, 1489:104-112.
363. Zhang L., Li Y., Zhang C., Chopp M., Gosiewska A., Hong K. Delayed administration of human umbilical tissue-derived cells improved neurological functional recovery in a rodent model of focal ischemia. Stroke 2011, 42:1437-1444.
364. Zhang P., Li J., Liu Y., Chen X., Kang Q. Transplanted human embryonic neural stem cells survive, migrate, differentiate and increase endogenous nestin expression in adult rat cortical peri-infarction zone. Neuropathology 2009, 29:410-421.
365. Zhang P., Li J., Liu Y., Chen X., Kang Q., Zhao J., Li W. Human neural stem cell transplantation attenuates apoptosis and improves neurological functions after cerebral ischemia in rats. Acta Anaesthesiologica Scandinavica 2009, 53:1184-1191.
366. Zhang P., Li J., Liu Y., Chen X., Lu H., Kang Q., Li W., Gao M. Human embryonic neural stem cell transplantation increases subventricular zone cell proliferation and promotes peri-infarct angiogenesis after focal cerebral ischemia. Neuropathology 2011, 31:384-391.
367. Zhang Z.G., Chopp M. Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic. Lancet Neurology 2009, 8:491-500.
368. Zhang Z.G., Zhang L., Jiang Q., Zhang R., Davies K., Powers C., Bruggen N., Chopp M. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. Journal of Clinical Investigation 2000, 106:829-838.
369. Zhao C., Deng W., Gage F.H. Mechanisms and functional implications of adult neurogenesis. Cell 2008, 132:645-660.
370. Zhao H., Yenari M.A., Cheng D., Sapolsky R.M., Steinberg G.K. Bcl-2 overexpression protects against neuron loss within the ischemic margin following experimental stroke and inhibits cytochrome c translocation and caspase-3 activity. Journal of Neurochemistry 2003, 85:1026-1036.
371. Zhao L.-R., Duan W.-M., Reyes M., Keene C.D., Verfaillie C.M., Low W.C. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Experimental Neurology 2002, 174:11-20.
372. Zhao M.Z., Nonoguchi N., Ikeda N., Watanabe T., Furutama D., Miyazawa D., Funakoshi H., Kajimoto Y., Nakamura T., Dezawa M., Shibata M.A., Otsuki Y., Coffin R.S., Liu W.D., Kuroiwa T., Miyatake S. Novel therapeutic strategy for stroke in rats by bone marrow stromal cells and ex vivo HGF gene transfer with HSV-1 vector. Journal of Cerebral Blood Flow and Metabolism 2006, 26:1176-1188.
373. Zhu W., Mao Y., Zhao Y., Zhou L.F., Wang Y., Zhu J.H., Zhu Y., Yang G.Y. Transplantation of vascular endothelial growth factor-transfected neural stem cells into the rat brain provides neuroprotection after transient focal cerebral ischemia. Neurosurgery 2005, 57:325-333. (discussion 325-333).